Neurological variability in chemotherapy-induced posterior reversible encephalopathy syndrome associated with thrombotic microangiopathy: Case reports and literature review.

about

Neurological variability in chemotherapy-induced posterior reversible encephalopathy syndrome associated with thrombotic microangiopathy: Case reports and literature review.

Item

http://www.wikidata.org/entity/Q50224262

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Neurological variability in ch ...... reports and literature review.

@en

Neurological variability in ch ...... reports and literature review.

@nl

type

Item

label

Neurological variability in ch ...... reports and literature review.

@en

Neurological variability in ch ...... reports and literature review.

@nl

prefLabel

Neurological variability in ch ...... reports and literature review.

@en

Neurological variability in ch ...... reports and literature review.

@nl

P1476

Neurological variability in ch ...... reports and literature review.

@en

P2093

Alexander Lossos

http://www.w3.org/2001/XMLSchema#string

Chen Makranz

http://www.w3.org/2001/XMLSchema#string

John Moshe Gomori

http://www.w3.org/2001/XMLSchema#string

Luna Kadouri

http://www.w3.org/2001/XMLSchema#string

Ruth Eliahou

http://www.w3.org/2001/XMLSchema#string

Salome Khutsurauli

http://www.w3.org/2001/XMLSchema#string

Yosef Kalish

http://www.w3.org/2001/XMLSchema#string

P2860

Tacrolimus induced leukoencephalopathy presenting with status epilepticus and prolonged coma

Gemcitabine-induced reversible posterior leukoencephalopathy syndrome: a case report and review of the literature

A reversible posterior leukoencephalopathy syndrome

Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed.

Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature.

Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer.

A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy.

Gemcitabine-associated hemolytic-uremic syndrome.

Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution.

The role of circulating immune complexes and biocompatibility of staphylococcal protein A immunoadsorption in mitomycin C-induced hemolytic uremic syndrome.

P304

178-182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MCO.2017.1476

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29387412

http://www.w3.org/2001/XMLSchema#string

P932

5768066

http://www.w3.org/2001/XMLSchema#string